You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Aelix and Gilead announce results of HIV infection candidate

Aelix – a company specialising in the discovery of therapies for HIV– has revealed the results of its AELIX-002 clinical study.